Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era ...

The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...

Head of Investor Relations Welcome to the Q4 and full year 2024 conference call for investors and analysts. As usual, you can find the slides on sanofi.com. Please turn to Slide 3. Here we have the ...

Side effects of biologic drugs may include: respiratory infections headaches flu-like symptoms swelling, itching, or a rash at the injection site urinary tract infection Two types of biologic ...

You may have already tried other treatments for your arthritis. These may have included over-the-counter pain medicines and corticosteroid injections. If you still have significant symptoms, ...

Dupilumab vs conventional AD therapies had less risk for anxiety, depression, and adjustment and sleep disorders, especially among Black patients. Patients with atopic dermatitis (AD) who were ...

Instead, he listed them on iPads handed to patients after they arrived, and instructed his employees never to take pictures of him performing injections, prosecutors said. When clients complained ...

A major new study has highlighted significant health risks associated with popular weight loss injections such as Ozempic, Wegovy, and Mounjaro. The research involved over two million patients and ...

The safety profile of dupilumab in EoE founded to be consistent with other atopic disease, both in adults and children. Injection site reactions, rhinopharyngitis, headache and nausea were the more ...

However, biologics like Dupixent (dupilumab) have paved the way for a new treatment paradigm, targeting specific inflammatory pathways to reduce exacerbations and improve patient outcomes.

The CEO discussed the success of Dupixent and the remarkable achievement of over $13 billion in global sales in 2024, highlighting its commercial advantage and setting a milestone for Sanofi.